{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:45:39Z","timestamp":1776872739832,"version":"3.51.2"},"reference-count":33,"publisher":"Bentham Science Publishers Ltd.","issue":"5","license":[{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CVP"],"published-print":{"date-parts":[[2020,8,10]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>In the current Thematic Issue of Current Vascular Pharmacology (CVP), entitled \u201cSystemic Autoimmune\nRheumatic Diseases and Cardiology\u201d, presented in two parts, Part 1 and Part 2, review articles are included from specialists\nin cardiology, rheumatology, immunology and related fields. These reviews discuss the cardiovascular complications\nof the main systemic Autoimmune Rheumatic Diseases (ARDs). For example, the underlying pathogenetic mechanisms,\nthe role of cardiovascular imaging and recommendations for prevention and management. These articles place inflammation\nas the key process, linking cardiovascular complications with ARDs. From all these reviews, the conclusion is the\nneed for collaboration between the disciplines of Rheumatology and Cardiology to establish the emerging field of Cardio-\nRheumatology. This will aid to fine-tune risk stratification and optimize preventive strategies and pharmacological therapies\nfor patients with ARDs.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570161118666200514222236","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T10:13:50Z","timestamp":1589537630000},"page":"425-430","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases \/ Is Inflammation the Common Link and Target?"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0336-4745","authenticated-orcid":true,"given":"Antonis S.","family":"Manolis","sequence":"first","affiliation":[{"name":"Third Department of Cardiology, Athens University, School of Medicine, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios G.","family":"Tzioufas","sequence":"additional","affiliation":[{"name":"Department of Pathopyhysiology, Athens University, School of Medicine, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","author":"England,BR.","unstructured":"England,BR.; Thiele,GM.; Anderson,DR.; Mikuls,TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ 2018; 361: k1036. http:\/\/dx.doi.org\/10.1136\/bmj.k1036 PMID: 29685876.","journal-title":"BMJ"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.autrev.2017.12.001","volume":"17(3)","author":"Lee,KS.","year":"2018","unstructured":"Lee,KS.; Kronbichler,A.; Eisenhut,M.; Lee,KH.; Shin,JI. Cardiovascular involvement in systemic rheumatic diseases: An integrated vi ew for the treating physicians. Autoimmun Rev. 2018; 17(3): 201-14. http:\/\/dx.doi.org\/10.1016\/j.autrev.2017.12.001 PMID: 29353099","journal-title":"Autoimmun Rev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11883-015-0497-6","volume":"17(4)","author":"Mankad,R","year":"2015","unstructured":"Mankad R. Atherosclerotic vascular disease in the autoimmune rheumatologic patient. Curr Atheroscler Rep. 2015; 17(4): 497. http:\/\/dx.doi.org\/10.1007\/s11883-015-0497-6 PMID: 25721102","journal-title":"Curr Atheroscler Rep"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2174\/1570161118666200129125320","volume":"18(5)","author":"Melissaropoulos,K.","year":"2020","unstructured":"Melissaropoulos,K.; Bogdanos,D.; Dimitroulas,T.; Sakkas,LI.; Kitas,GD.; Daoussis,D. Primary Sj\u00f6gren\u2019s syndrome and cardiovascular di sease. Curr Vasc Pharmacol. 2020; 18(5): 447-54. http:\/\/dx.doi.org\/10.2174\/1570161118666200129125320 PMID: 31995009","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=5","doi-asserted-by":"publisher","DOI":"10.2174\/1570161118666191227101636","author":"Kostopoulou,M.","unstructured":"Kostopoulou,M.; Nikolopoulos,D.; Parodis,I.; Bertsias,G. Cardiovascular disease in systemic lupus erythematosus: recent data on ep idemiology, risk factors and prevention. Curr Vasc Pharmacol. 2019; Epub ahead of print http:\/\/dx.doi.org\/10.2174\/1570161118666191227101636 PMID: 31880245","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2174\/1570161117666190426164306","volume":"18(5)","author":"Papagoras,C.","year":"2020","unstructured":"Papagoras,C.; Voulgari,P.; Drosos,A. Cardiovascular disease in spondyloarthr itides. Curr Vasc Pharmacol. 2020; 18(5): 473-87. http:\/\/dx.doi.org\/10.2174\/1570161117666190426164306 PMID: 31330576","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2174\/1570161117666190619143842","volume":"18(5)","author":"Fragoulis,GE.","year":"2020","unstructured":"Fragoulis,GE.; Panayotidis,I.; Nikiphorou,E. Cardiovascular risk in rheumatoid arthr itis and mechanistic links: from pathophysiology to treatment. Curr Vasc Pharmacol. 2020; 18(5): 431-46. http:\/\/dx.doi.org\/10.2174\/1570161117666190619143842 PMID: 31258091","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1002\/art.21954","volume":"54(7)","author":"Stea,EA.","year":"2006","unstructured":"Stea,EA.; Routsias,JG.; Clancy,RM.; Buyon,JP.; Moutsopoulos,HM.; Tzioufas,AG. Anti-La\/SSB an tiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring. Arthr itis Rheum. 2006; 54(7): 2228-34. http:\/\/dx.doi.org\/10.1002\/art.21954 PMID: 16802359","journal-title":"Arthr itis Rheum"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.tcm.2019.06.006","volume":"30(5)","author":"Manolis,AA.","year":"2020","unstructured":"Manolis,AA.; Manolis,TA.; Melita,H.; Manolis,AS. Congenital heart block: Pace earlier (Childhood)  than later (Adulthood) . Trends C ardiovasc Med. 2020; 30(5): 275-86. http:\/\/dx.doi.org\/10.1016\/j.tcm.2019.06.006","journal-title":"Trends Cardiovasc Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1111\/bph.14604","volume":"176(12)","author":"Taylor,EB.","year":"2019","unstructured":"Taylor,EB.; Wolf,VL.; Dent,E.; Ryan,MJ. Mechanisms of hypertension in autoimmune rheumatic diseases. Br J Pharmacol. 2019; 176(12): 1897-913. http:\/\/dx.doi.org\/10.1111\/bph.14604 PMID: 30714094","journal-title":"Br J Pharmacol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrcardio.2017.118","volume":"15(1)","author":"Bartoloni,E.","year":"2018","unstructured":"Bartoloni,E.; Alunno,A.; Gerli,R. Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases. Nat Rev Cardiol. 2018; 15(1): 33-44. http:\/\/dx.doi.org\/10.1038\/nrcardio.2017.118 PMID: 28836617","journal-title":"Nat Rev Cardiol"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.2174\/1570161118666200127142936","author":"Atzeni,F.","unstructured":"Atzeni F, Nucera V, Gerratana E.;et al. Cardiovascular consequences of autoimmune rheumatic diseases. Curr Vasc Pharmacol. 2019; Epub ahead of print http:\/\/dx.doi.org\/10.2174\/1570161118666200127142936 PMID: 31985379","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1042\/CS20090557","volume":"118(10)","author":"Van,der Heiden,K.","year":"2010","unstructured":"Van,der Heiden,K.; Cuhlmann,S.; Luong,A.; Zakkar,M.; Evans,PC. Role of nuclear factor kappaB in cardiovascular health and disease. Clin Sci. 2010; 118(10): 593-605. http:\/\/dx.doi.org\/10.1042\/CS20090557 PMID: 20175746","journal-title":"Clin Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/ar3324","volume":"13(3)","author":"van Loo,G.","year":"2011","unstructured":"van Loo,G.; Beyaert,R. Negative regulation of NF-?B and its involvement in rheumatoid arthr itis. Arthritis Res Ther. 2011; 13(3): 221. http:\/\/dx.doi.org\/10.1186\/ar3324 PMID: 21639951","journal-title":"Arthritis Res Ther"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/ar2457","volume":"10(4)","author":"Brown,KD.","year":"2008","unstructured":"Brown,KD.; Claudio,E.; Siebenlist,U. The roles of the classical and alternative nuclear factor-kappaB pathways: potential implica tions for autoimmunity and rheumatoid arthritis. Arthritis Res Ther. 2008; 10(4): 212. http:\/\/dx.doi.org\/10.1186\/ar2457 PMID: 18771589","journal-title":"Arthritis Res Ther"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2174\/1570161117666190930113837","volume":"18(5)","author":"Mourouzis,IS.","year":"2020","unstructured":"Mourouzis,IS.; Manolis,AS.; Pantos,C. Cardiovascular risk of synthetic, non-biologic disease-modifying anti-rheumatic drugs (DMAR Ds) . Curr Vasc Pharmacol. 2020; 18(5): 455-62. http:\/\/dx.doi.org\/10.2174\/1570161117666190930113837 PMID: 31566134","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2174\/1570161118666200214115532","volume":"18(5)","author":"Drakopoulou,M.","year":"2020","unstructured":"Drakopoulou,M.; Soulaidopoulos,S.; Oikonomou,G.; Toutouzas,K.; Tousoulis,D. Cardiovascular effects of biologic disease-modifying an ti-rheumatic drugs (DMARDs) . Curr Vasc Pharmacol. 2020; 18(5): 488-506. http:\/\/dx.doi.org\/10.2174\/1570161118666200214115532 PMID: 32056527","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2174\/1570161118666200130093432","volume":"18(5)","author":"Soulaidopoulos,S.","year":"2020","unstructured":"Soulaidopoulos S, Madenidou AV, Daoussis D.;et al. Cardiovascular disease in the Systemic Vasculitides. Curr Vasc Pharmacol. 2020; 18(5): 463-72. http:\/\/dx.doi.org\/10.2174\/1570161118666200130093432 PMID: 32000652","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/europace\/eut290","volume":"16(6)","author":"Teixeira,RA.","year":"2014","unstructured":"Teixeira RA, Borba EF, Pedrosa A.;et al. Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus. Eu-ropace. 2014; 16(6): 887-92. http:\/\/dx.doi.org\/10.1093\/europace\/eut290 PMID: 24050965","journal-title":"Eu-ropace"},{"key":"ref=20","first-page":"195","volume":"7","author":"Manolis,AS.","year":"2012","unstructured":"Manolis,AS.; Manolis,TA.; Melita,H. Atherosclerosis: an athero-thrombo-inflammatory disease. Hosp Chron. 2012; 7: 195-201","journal-title":"Hosp Chron"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/08830185.2018.1539084","volume":"38(1)","author":"Manolis,AA.","year":"2019","unstructured":"Manolis,AA.; Manolis,TA.; Melita,H.; Manolis,AS. Psoriasis and cardiovascular disease: the elusive link. Int Rev Immunol. 2019; 38(1): 33-54. http:\/\/dx.doi.org\/10.1080\/08830185.2018.1539084 PMID: 30457023","journal-title":"Int Rev Immunol"},{"key":"ref=22","doi-asserted-by":"publisher","DOI":"10.2174\/1570161118666200523154318","author":"Kapniari,E.","unstructured":"Kapniari E, Papadimitriou P, Dalamaga M.;et al. Investigating the link between psoriasis and cardiovascular disease: current evidence, therapeutic impli-cations and perspectives. Curr Vasc Pharmacol. 2020; Epub ahead of print http:\/\/dx.doi.org\/10.2174\/1570161118666200523154318 PMID: 32445456","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=23","author":"Polytarchou,K.","unstructured":"Polytarchou,K.; Varvarousis,D.; Manolis,AS. Cardiovascular Disease in Antiphospholipid Syndrome. Curr Vasc Pharmacol 2019. Epub a head of print http:\/\/dx.doi.org\/10.2174\/1570161117666190830101341 PMID: 31530257.","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=24","author":"Arsenaki,E.","unstructured":"Arsenaki E, Georgakopoulos P, Mitropoulou P.;et al. Cardiovascular disease in Juvenile Idiopathic Arthritis. Curr Vasc Pharmacol 2020. Epub ahead of print http:\/\/dx.doi.org\/10.2174\/1570161118666200408121307 PMID: 32268865","journal-title":"Curr Vasc Pharmacol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/OARRR.S157229","volume":"10","author":"Sule,S.","year":"2018","unstructured":"Sule,S.; Fontaine,K. Metabolic syndrome in adults with a history of juvenile arthr itis. Open Access Rheumatol. 2018; 10: 67-72. http:\/\/dx.doi.org\/10.2147\/OARRR.S157229 PMID: 29922101","journal-title":"Open Access Rheumatol"},{"key":"ref=26","author":"Aulie,HA.","unstructured":"Aulie,HA.; Estensen,ME.; Selvaag,AM.; Lilleby,V.; Flat\u00f8 B.; Aa,khus,S. Arterial properties in adults with long-lasting active juvenile idiopathic arthritis compared to healthy controls. Pediatr Rheumatol Online J 2018; 16(1): 85. http:\/\/dx.doi.org\/10.1186\/s12969-018-0302-5 PMID: 30594204.","journal-title":"Pediatr Rheumatol Online"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s10067-016-3254-5","volume":"35(7)","author":"Sozeri,B.","year":"2016","unstructured":"Sozeri,B.; Atikan,BY.; Ozdemir,K.; Mir,S. Assessment of vascular function in systemic onset juvenile idiopathic arthritis. Clin Rh eumatol. 2016; 35(7): 1699-703. http:\/\/dx.doi.org\/10.1007\/s10067-016-3254-5 PMID: 27075461","journal-title":"Clin Rh eumatol"},{"key":"ref=28","first-page":"34","volume":"6(1)","author":"Mani,P.","year":"2016","unstructured":"Mani P, Uno K, Duong M.;et al. HDL function and subclinical atherosclerosis in juvenile idiopathic arthritis. Cardiovasc Diagn Ther. 2016; 6(1): 34-43. PMID: 26885490","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3899\/jrheum.150499","volume":"43(4)","author":"Evensen,K.","year":"2016","unstructured":"Evensen,K.; Aulie,HA.; R\u00f8nning,OM.; Flat\u00f8 B.; Russell,D. Carotid atherosclerosis in adult patients with persistently active juvenil e idiopathic arthritis compared with healthy controls. J Rheumatol. 2016; 43(4): 810-5. http:\/\/dx.doi.org\/10.3899\/jrheum.150499 PMID: 26879363","journal-title":"J Rheumatol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/03009742.2015.1126345","volume":"45(4)","author":"Anderson,JH.","year":"2016","unstructured":"Anderson JH, Anderson KR, Aulie HA.;et al. Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study. Scand J Rheuma-tol. 2016; 45(4): 299-303. http:\/\/dx.doi.org\/10.3109\/03009742.2015.1126345 PMID: 26854592","journal-title":"Scand J Rheuma-tol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00296-016-3534-z","volume":"37(1)","author":"Koca,B.","year":"2017","unstructured":"Koca,B.; Sahin,S.; Adrovic,A.; Barut,K.; Kasapcopur,O. Cardiac involvement in juvenile idiopathic arthr itis. Rheumatol Int. 2017; 37(1): 137-42. http:\/\/dx.doi.org\/10.1007\/s00296-016-3534-z PMID: 27417551","journal-title":"Rheumatol Int"},{"key":"ref=32","first-page":"796","volume":"31(5)","author":"Raab,A.","year":"2013","unstructured":"Raab A, Sengler C, Niewerth M.;et al. Comorbidity profiles among adult patients with juvenile idiopathic arthritis: results of a biologic register. Clin Exp Rheumatol. 2013; 31(5): 796-802. PMID: 23557722","journal-title":"Clin Exp Rheumatol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrcardio.2014.206","volume":"12(3)","author":"Prasad,M.","year":"2015","unstructured":"Prasad M, Hermann J, Gabriel SE.;et al. Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nat Rev Cardiol. 2015; 12(3): 168-76. http:\/\/dx.doi.org\/10.1038\/nrcardio.2014.206 PMID: 25533796","journal-title":"Nat Rev Cardiol"}],"container-title":["Current Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/181965","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/181965\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/181965","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T15:39:14Z","timestamp":1609774754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/181965\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,8,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570161118666200514222236","relation":{},"ISSN":["1570-1611"],"issn-type":[{"value":"1570-1611","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}